z-logo
Premium
NAG7 promotes human nasopharyngeal carcinoma invasion through inhibition of estrogen receptor alpha and up‐regulation of JNK2/AP‐1/MMP1 pathways
Author(s) -
Huang Chen,
Wu Minghua,
Tang Yunlian,
Li Xiaoling,
Ouyang Jue,
Xiao Lan,
Li Dan,
Li Guiyuan
Publication year - 2009
Publication title -
journal of cellular physiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.529
H-Index - 174
eISSN - 1097-4652
pISSN - 0021-9541
DOI - 10.1002/jcp.21867
Subject(s) - nasopharyngeal carcinoma , cancer research , biology , estrogen receptor , regulator , estrogen , signal transduction , mmp1 , receptor , microbiology and biotechnology , medicine , endocrinology , gene expression , cancer , biochemistry , gene , genetics , breast cancer , radiation therapy
The NAG7 , an estrogen receptor repressor, is a negative regulator of nasopharyngeal carcinoma cell growth. Here, we report that NAG7 promotes human nasopharyngeal carcinoma invasion, and we identify the mechanisms underlying this function. As a consequence of elevated NAG7 expression, the adhesion, migration, and invasive capabilities of HNE1 cells in vitro and in vivo were enhanced. NAG7 was a significant negative regulator of protein expression of estrogen receptor alpha (ERα), and activated both the JNK2/AP‐1/MMP1 and the upstream H‐Ras/p‐c‐Raf pathways. None of these effects induced by NAG7 over‐expression could be counteracted by estrogen. These observations indicate that NAG7 plays a potential role in promoting nasopharyngeal carcinoma invasion by regulation of ERα and the H‐ras/p‐c‐Raf and JNK2/AP‐1/MMP1 signaling pathways. J. Cell. Physiol. 221: 394–401, 2009. © 2009 Wiley‐Liss, Inc.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom